Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 4/2014

01-04-2014 | Original Paper

Effectiveness of Mindfulness-Based Cognitive Therapy on the Quality of Life, Emotional Status, and CD4 Cell Count of Patients Aging with HIV Infection

Authors: Marian Gonzalez-Garcia, Maria Jose Ferrer, Xavier Borras, Jose A. Muñoz-Moreno, Cristina Miranda, Jordi Puig, Nuria Perez-Alvarez, Joaquim Soler, Albert Feliu-Soler, Bonaventura Clotet, Carmina R. Fumaz

Published in: AIDS and Behavior | Issue 4/2014

Login to get access

Abstract

Long-term diagnosed and treated HIV-infected patients have to cope with a wide range of challenges that threaten their ability to age successfully. We report the results of a randomized controlled trial testing the effects of a mindfulness-based cognitive therapy (MBCT) program on quality of life (QoL), emotional status, and immune status over a 3-month period. Forty HIV-infected patients diagnosed prior to 1996 and on cART for a minimum of 5 years were randomized to follow an MBCT program (n = 20) or remain as controls (routine follow-up) (n = 20). A regression analysis was performed, and the measurement of effect size was estimated using Cohen’s d. QoL, psychological stress, depressive symptoms, and anxiety symptoms improved in the MBCT group compared with the control group. During follow-up, patients in the MBCT group had a significantly increased CD4 cell count. Effect sizes for MBCT on the variables assessed were large (d = 0.8). The findings suggest that this program may help to promote successful aging in these patients.
Literature
1.
Mrus JM, Leonard AC, Yi MS, et al. Health-related quality of life in veterans and non-veterans with HIV/AIDS. J Gen Intern Med. 2006;21(Suppl 5):S39–47.PubMedCentralPubMedCrossRef
2.
Lohse N, Hansen AB, Pedersen G, et al. Survival of persons with and without HIV infection in Denmark, 1995–2005. Ann Intern Med. 2007;146(2):87–95.PubMedCrossRef
3.
Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;372(9635):293–9.CrossRef
4.
May M, Gompels M, Delpech V, et al. Impact of late diagnosis and treatment on life-expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study. BMJ. 2011;343:d6016.PubMedCentralPubMedCrossRef
5.
Effros RB, Fletcher CV, Gebo K, et al. Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. Clin Infect Dis. 2008;47(4):542–53.PubMedCentralPubMedCrossRef
6.
7.
Bhatia R, Ryscavage P, Taiwo B. Accelerated aging and human immunodeficiency virus infection: emerging challenges of growing older in the era of successful antiretroviral therapy. J Neurovirol. 2012;18(4):247–55.PubMedCrossRef
8.
Guaraldi G, Orlando G, Zona S, et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis. 2011;53(11):1120–6.PubMedCrossRef
9.
Capeau J. Premature aging and premature age-related comorbidities in HIV-infected patients: facts and hypotheses. Clin Infect Dis. 2011;53(11):1127–9.PubMedCrossRef
10.
11.
Bing EG, Hays RD, Jacobson LP, et al. Health-related quality of life among people with HIV disease: results from the Multicenter AIDS Cohort Study. Qual Life Res. 2000;9(1):55–63.PubMedCrossRef
12.
Davis S. Clinical sequelae affecting quality of life in the HIV-infected patient. J Assoc Nurses AIDS Care. 2004;15(Suppl 5):28S–33S.PubMedCrossRef
13.
Silverman GK, Jacobs SC, Kasl SV, et al. Quality of life impairments associated with diagnostic criteria for traumatic grief. Psychol Med. 2000;30(4):857–62.PubMedCrossRef
14.
Liu C, Johnson L, Ostrow D, Silvestre A, Vusscher B, Jacobson LP. Predictors for lower quality of life in the HAART era among HIV-infected men. J Acquir Immune Defic Syndr. 2006;42(4):470–7.PubMedCrossRef
15.
Burgess AP, Carretero M, Elkington A, Pasqual-Marsettin E, Lobaccaro C, Catalán J. The role of personality, coping style and social support in health-related quality of life in HIV infection. Qual Life Res. 2000;9(4):423–37.PubMedCrossRef
16.
Vance DE, Struzick T, Childs G. Challenges of depression and suicidal ideation associated with aging with HIV/AIDS: implications for social work. J Gerontol Soc Work. 2010;53(2):159–75.PubMedCrossRef
17.
Owen G, Catalan J. ‘We never expected this to happen’: narratives of ageing with HIV among gay men living in London, UK. Cult Health Sex. 2012;14(1):59–72.PubMedCrossRef
18.
Fumaz CR, Muñoz-Moreno JA, Ferrer MJ, et al. Emotional impact of premature aging symptoms in long-term treated HIV-infected subjects. J Acquir Immune Defic Syndr. 2012;59(1):e5–8.PubMedCrossRef
19.
Irwin MR. Human psychoneuroimmunology: 20 years of discovery. Brain Behav Immun. 2008;22(2):129–39.PubMedCrossRef
20.
Leserman J. Role of depression, stress, and trauma in HIV disease progression. Psychosom Med. 2008;70(5):539–45.PubMedCrossRef
21.
Bottonari KA, Safren SA, McQuaid JR, Hsiao C-B, Roberts JE. A longitudinal investigation of the impact of life stress on HIV treatment adherence. J Behav Med. 2010;33(6):486–95.PubMedCentralPubMedCrossRef
22.
Campos LN, Guimaraes MD, Remien RH. Anxiety and depression symptoms as risk factors for non-adherence to antiretroviral therapy in Brazil. AIDS Behav. 2010;14(2):289–99.PubMedCentralPubMedCrossRef
23.
Kacanek D, Jacobson DL, Spiegelman D, Wanke C, Isaac R, Wilson IB. Incident depression symptoms are associated with poorer HAART adherence: a longitudinal analysis from the nutrition for healthy living study. J Acquir Immune Defic Syndr. 2010;53(2):266–72.PubMedCentralPubMedCrossRef
24.
Logsdon-Conradsen S. Using mindfulness meditation to promote holistic health in individuals with HIV/AIDS. Cogn Behav Pract. 2002;9(1):67–72.CrossRef
25.
High KP, Brennan-Ing M, Clifford DB, et al. HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr. 2012;60(Suppl 1):S1–18.PubMedCrossRef
26.
Carlson LE. Mindfulness-based interventions for physical conditions: a narrative review evaluating levels of evidence. ISRN Psychiatry. 2012;2012:651583.PubMedCentralPubMedCrossRef
27.
Segal ZV, Williams JMG, Teasdale JD. Mindfulness-based cognitive therapy for depression: a new approach to preventing relapse. New York: Guilford Press; 2002.
28.
Kabat-Zinn J. Full catastrophe living: using the wisdom of your body and mind to face stress, pain, and illness. New York: Delta; 1990.
29.
Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive therapy of depression. New York: Guilford Press; 1979.
30.
Foley E, Baillie A, Huxter M, Price M, Sinclair E. Mindfulness-based cognitive therapy for individuals whose lives have been affected by cancer: a randomized controlled trial. J Consult Clin Psychol. 2010;78(1):72–9.PubMedCrossRef
31.
Moustgaard AK. Mindfulness-based cognitive therapy (MBCT) for stroke survivors: an application of a novel intervention. Doctoral dissertation, Lakehead University, Canada; 2005.
32.
Sibinga EM, Stewart M, Magyari T, Welsh CK, Hutton N, Ellen JM. Mindfulness-based stress reduction for HIV-infected youth: a pilot study. Explore (NY). 2008;4(1):36–7.PubMedCrossRef
33.
Duncan LG, Moskowitz JT, Neilands TB, Dilworth SE, Hecht FM, Johnson MO. Mindfulness-based stress reduction for HIV treatment side effects: a randomized, wait-list controlled trial. J Pain Symptom Manage. 2012;43(2):161–71.PubMedCentralPubMedCrossRef
34.
Gayner B, Esplen MJ, Deroche P, et al. A randomized controlled trial of mindfulness-based stress reduction to manage affective symptoms and improve quality of life in gay men living with HIV. J Behav Med. 2012;35(3):272–85.PubMedCrossRef
35.
Robinson FP, Mathews HL, Witek-Janusez L. Psycho-endocrine-immune response to mindfulness-based stress reduction in individuals infected with the human immunodeficiency virus: a quasiexperimental study. J Altern Complement Med. 2003;9(5):683–94.PubMedCrossRef
36.
Creswell JD, Myers HF, Cole SW, Irwin MR. Mindfulness meditation training effects on CD4+ T lymphocytes in HIV-1 infected adults: a small randomized controlled trial. Brain Behav Immun. 2009;23(2):184–8.PubMedCentralPubMedCrossRef
37.
Jam S, Imani AH, Foroughi M, SeyedAlinaghi S, Koochak HE, Mohraz M. The effects of mindfulness-based stress reduction (MBSR) program in Iranian HIV/AIDS patients: a pilot study. Acta Med Iran. 2010;48(2):101–6.PubMed
38.
SeyedAlinaghi S, Jam S, Foroughi M, et al. Randomized controlled trial of mindfulness-based stress reduction delivered to human immunodeficiency virus-positive patients in Iran: effects on CD4+ T lymphocyte count and medical and psychological symptoms. Psychosom Med. 2012;74(6):620–7.PubMedCentralPubMedCrossRef
39.
Weston E, Moran P, Acree M, et al. Effect of MBSR and psychological state on inflammatory markers in HIV positive adults. BMC Complement Altern Med. 2012;12(Suppl 1):O6.PubMedCentralCrossRef
40.
Wood NA. Mindfulness-based cognitive therapy for the symptoms of depression in a community-based HIV/AIDS Clinic: outcomes and feasibility. Chester: Widener University; 2008.
41.
Teasdale JD, Segal ZV, Williams JMG, Ridgeway VA, Soulsby JM, Lau MA. Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. J Consult Clin Psychol. 2000;68(4):615–23.PubMedCrossRef
42.
Tuldrà A, Fumaz CR, Ferrer MJ, et al. Prospective randomized two-arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy. J Acquir Inmune Defic Syndr. 2000;25(3):221–8.CrossRef
43.
Fumaz CR, Muñoz-Moreno JA, Moltó J, et al. Sustained antiretroviral treatment adherence in survivors of the pre-HAART era: attitudes and beliefs. AIDS Care. 2008;20(7):796–805.PubMedCrossRef
44.
Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21–30.PubMedCrossRef
45.
Hendricks K, Tang A, Spiegelman D, Skinner S, Woods M. Dietary intake in human immunodeficiency virus-infected adults: a comparison of dietary assessment methods. J Am Diet Assoc. 2005;105(4):532–40.PubMedCrossRef
46.
Mitrou PN, Kipnis V, Thiébaut AC, et al. Mediterranean dietary pattern and prediction of all-cause mortality in a US population: results from the NIH-AARP Diet and Health Study. Arch Intern Med. 2007;167(22):2461–8.PubMedCrossRef
47.
Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837–47.PubMedCrossRef
48.
Hunt SM, McKenna SP, McEwen J, Williams J, Papp E. The Nottingham Health Profile: subjective health status and medical consultations. Soc Sci Med A. 1981;15(3 Pt 1):221–9.PubMed
49.
Alonso J, Anto JM, Moreno C. Spanish version of the Nottingham Health Profile: translation and preliminary validity. Am J Public Health. 1990;80(6):704–8.PubMedCentralPubMedCrossRef
50.
Alonso J, Prieto L, Antó JM. The Spanish version of the Nottingham Health Profile: a review of adaptation and instrument characteristics. Qual Life Res. 1994;3(6):385–93.PubMedCrossRef
51.
Badia X, Alonso J, Brosa M, Lock P. Reliability of the Spanish version of the Nottingham Health Profile in patients with stable end-stage renal disease. Soc Sci Med. 1994;38(1):153–8.PubMedCrossRef
52.
Permanyer-Miralda G, Alonso J, Antó JM, Alijarde-Guimerá M, Soler–Soler J. Comparison of perceived health status and conventional functional evaluation in stable patients with coronary artery disease. J Clin Epidemiol. 1991;44(8):779–86.PubMedCrossRef
53.
Cohen S, Williamson G. Perceived stress in a probability sample of the United States. In: Spacapan S, Oskamp S, editors. The social psychology of health: Claremont symposium on applied social psychology. Newbury Park: Sage; 1988. p. 31–67.
54.
Remor E. Psychometric properties of a European Spanish version of the Perceived Stress Scale (PSS). Span J Psychol. 2006;9(1):86–93.PubMed
55.
Beck AT, Steer R, Brown GK. BDI-II: Beck Depression Inventory. 2nd ed. San Antonio: The Psychological Corporation; 1996.
56.
Sanz J, García MP, Espinosa R, et al. Adaptación española del Inventario para la Depresión de Beck-II (BDI-II): 3. Propiedades psicométricas en pacientes con trastornos psicológicos. Clínica y Salud. 2005;16(2):121–42.
57.
Beck AT, Brown G, Epstein N, et al. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56(6):893–7.PubMedCrossRef
58.
Sanz J, Navarro ME. Propiedades psicométricas de una versión española del Inventario de Ansiedad de Beck (BAI) en estudiantes universitarios. Ansiedad y Estrés. 2003;9(1):59–84.
59.
Sanz J, Garcia-Vera MP, Fortun M. El “inventario de ansiedad de beck” (BAI): propiedades psicométricas de la versión española en pacientes con trastornos psicológicos. The Free Library (2012, September 1). http://​www.​thefreelibrary.​com/​El “inventario de ansiedad de beck” (BAI): propiedades psicometricas…-a0314254361. Accessed 2 July 2013.
60.
Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale: Lawrence Erlbaum Associates; 1988.
61.
Casado JM, González N, Moraleda S, Orueta R, Carmona J, Gomez-Calcerrada RM. Calidad de vida relacionada con la salud en pacientes ancianos en atención primaria. Atención Primaria. 2001;28(3):167–73.PubMedCrossRef
62.
Ozturk A, Simşek T, Yümin ET, Sertel M, Yümin M. The relationship between physical, functional capacity and quality of life (QoL) among elderly people with a chronic disease. Arch Gerontol Geriatr. 2011;53(3):278–83.PubMedCrossRef
63.
Kuyken W, Byford S, Taylor RS, et al. Mindfulness-based cognitive therapy to prevent relapse in recurrent depression. J Consult Clin Psychol. 2008;76(6):966–78.PubMedCrossRef
64.
Godfrin KA, van Heeringen C. The effects of mindfulness-based cognitive therapy on recurrence of depressive episodes, mental health and quality of life: a randomized controlled study. Behav Res Ther. 2010;48(8):738–46.PubMedCrossRef
65.
Splevins K, Smith A, Simpson J. Do improvements in emotional distress correlate with becoming more mindful? A study of older adults. Aging Ment Health. 2009;13(3):328–35.PubMedCrossRef
66.
Baer RA. Mindfulness training as a clinical intervention: a conceptual and empirical review. Clin Psychol Sci Pract. 2003;10(2):125–43.CrossRef
67.
Finucane A, Mercer SW. An exploratory mixed methods study of the acceptability and effectiveness of mindfulness-based cognitive therapy for patients with active depression and anxiety in primary care. BMC Psychiatry. 2006;6:14.PubMedCentralPubMedCrossRef
68.
Kenny M, Williams JM. Treatment-resistant depressed patients show a good response to mindfulness-based cognitive therapy. Behav Res Ther. 2007;45(3):617–25.PubMedCentralPubMedCrossRef
69.
Fumaz CR, Gonzalez-Garcia M, Borras X, et al. Psychological stress is associated with high levels of IL-6 in HIV-1 infected individuals on effective combined antiretroviral treatment. Brain Behav Immun. 2012;26(4):568–72.PubMedCrossRef
70.
Witek-Janusek L, Albuquerque K, Chroniak KR, Chroniak C, Durazo-Arvizu R, Mathews HL. Effect of mindfulness based stress reduction on immune function, quality of life and coping in women newly diagnosed with early stage breast cancer. Brain Behav Immun. 2008;22(6):969–81.PubMedCentralPubMedCrossRef
71.
Brewer JA, Mallik S, Babuscio TA, et al. Mindfulness training for smoking cessation: results from a randomized controlled trial. Drug Alcohol Depend. 2011;119(1–2):72–80.PubMedCentralPubMedCrossRef
Metadata
Title
Effectiveness of Mindfulness-Based Cognitive Therapy on the Quality of Life, Emotional Status, and CD4 Cell Count of Patients Aging with HIV Infection
Authors
Marian Gonzalez-Garcia
Maria Jose Ferrer
Xavier Borras
Jose A. Muñoz-Moreno
Cristina Miranda
Jordi Puig
Nuria Perez-Alvarez
Joaquim Soler
Albert Feliu-Soler
Bonaventura Clotet
Carmina R. Fumaz
Publication date
01-04-2014
Publisher
Springer US
Published in
AIDS and Behavior / Issue 4/2014
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-013-0612-z

Other articles of this Issue 4/2014

AIDS and Behavior 4/2014 Go to the issue

Original Paper

Travel Distance to HIV Medical Care: A Geographic Analysis of Weighted Survey Data from the Medical Monitoring Project in Philadelphia, PA

Guest Editorial

Development of Year 2020 Goals for the National HIV/AIDS Strategy for the United States

Commentary

Moving the Bar to the Right Place: Positioning Interventions in HIV Prevention

Original Paper

The Use of Cell Phone Support for Non-adherent HIV-Infected Youth and Young Adults: An Initial Randomized and Controlled Intervention Trial

Brief Report

The Impact of Alcohol Use on HIV/STI Intervention Efficacy in Predicting Sexually Transmitted Infections Among Young African-American Women

Letter to the Editor

Examining the Authors’ Choice of Secondary Data in Determining What Factors Affect HIV Prevalence in WMSM, BMSM and Transgender Populations
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits